Flora Growth Corp. (FLGC)
USD 0.5
(2.27%)
USD 0.5
(2.27%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -57.03 Million USD | -2.4% |
| 2022 | -52.62 Million USD | -146.38% |
| 2021 | -21.36 Million USD | -49.81% |
| 2020 | -14.25 Million USD | -401.35% |
| 2019 | -2.84 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -2.63 Million USD | 22.05% |
| 2024 Q1 | -3.37 Million USD | 59.28% |
| 2023 Q1 | -3.9 Million USD | 68.82% |
| 2023 FY | -53.89 Million USD | -2.4% |
| 2023 Q4 | -8.28 Million USD | -769.77% |
| 2023 Q3 | 1.23 Million USD | 102.78% |
| 2023 Q2 | -44.55 Million USD | -1041.0% |
| 2022 Q2 | -43.09 Million USD | -472.66% |
| 2022 FY | -52.62 Million USD | -146.38% |
| 2022 Q1 | -7.52 Million USD | 40.01% |
| 2022 Q4 | -12.52 Million USD | -70.22% |
| 2022 Q3 | -7.35 Million USD | 82.93% |
| 2021 FY | -21.36 Million USD | -49.81% |
| 2021 Q1 | -2.54 Million USD | 56.12% |
| 2021 Q4 | -12.54 Million USD | -247.67% |
| 2021 Q3 | -3.6 Million USD | -21.97% |
| 2021 Q2 | -2.95 Million USD | -16.07% |
| 2020 Q3 | -5.8 Million USD | -241.47% |
| 2020 Q2 | -1.7 Million USD | -92.41% |
| 2020 FY | -14.25 Million USD | -401.35% |
| 2020 Q1 | -883.91 Thousand USD | 0.0% |
| 2020 Q4 | -5.8 Million USD | 0.0% |
| 2019 Q2 | -1.89 Million USD | 0.0% |
| 2019 FY | -2.84 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 48.15 Million USD | 218.443% |
| China SXT Pharmaceuticals, Inc. | -3.09 Million USD | -1740.743% |
| Embecta Corp. | 70.4 Million USD | 181.017% |
| Pacira BioSciences, Inc. | 41.95 Million USD | 235.946% |
| PainReform Ltd. | -9.34 Million USD | -510.402% |
| Sunshine Biopharma, Inc. | -4.5 Million USD | -1165.767% |
| SCYNEXIS, Inc. | 67.04 Million USD | 185.076% |
| Journey Medical Corporation | -3.85 Million USD | -1380.301% |
| Safety Shot Inc | -15.08 Million USD | -278.147% |
| Alpha Teknova, Inc. | -36.78 Million USD | -55.073% |
| Bright Green Corporation | -13.12 Million USD | -334.472% |
| Procaps Group, S.A. | 42.54 Million USD | 234.076% |
| Alvotech | -551.73 Million USD | 89.662% |
| ANI Pharmaceuticals, Inc. | 18.77 Million USD | 403.722% |
| Aquestive Therapeutics, Inc. | -7.87 Million USD | -624.727% |
| Cosmos Health Inc. | -18.54 Million USD | -207.594% |
| Dynavax Technologies Corporation | -6.38 Million USD | -792.722% |
| Esperion Therapeutics, Inc. | -209.24 Million USD | 72.742% |
| Intra-Cellular Therapies, Inc. | -139.67 Million USD | 59.165% |
| Sunshine Biopharma, Inc. | -4.5 Million USD | -1165.767% |
| Theratechnologies Inc. | -23.95 Million USD | -138.077% |
| Harrow Health, Inc. | -24.41 Million USD | -133.649% |
| Sonoma Pharmaceuticals, Inc. | -4.83 Million USD | -1079.648% |
| Biofrontera Inc. | -20.13 Million USD | -183.324% |
| DURECT Corporation | -27.62 Million USD | -106.473% |
| Supernus Pharmaceuticals, Inc. | 1.31 Million USD | 4434.043% |
| Cronos Group Inc. | -73.96 Million USD | 22.886% |
| OptiNose, Inc. | -35.48 Million USD | -60.742% |
| Ironwood Pharmaceuticals, Inc. | -1 Billion USD | 94.309% |
| Kala Pharmaceuticals, Inc. | -42.19 Million USD | -35.16% |
| RedHill Biopharma Ltd. | 23.91 Million USD | 338.485% |
| Organogenesis Holdings Inc. | 4.94 Million USD | 1253.407% |
| Guardion Health Sciences, Inc. | 158.03 Thousand USD | 36191.196% |
| Cumberland Pharmaceuticals Inc. | -6.27 Million USD | -808.315% |
| Radius Health, Inc. | -25.79 Million USD | -121.147% |
| Universe Pharmaceuticals INC | -6.16 Million USD | -825.449% |
| ProPhase Labs, Inc. | -16.78 Million USD | -239.864% |
| Phibro Animal Health Corporation | 2.41 Million USD | 2460.762% |
| Procaps Group S.A. | 42.54 Million USD | 234.076% |
| TherapeuticsMD, Inc. | -10.27 Million USD | -454.933% |
| Viatris Inc. | 54.7 Million USD | 204.271% |
| Rockwell Medical, Inc. | -8.43 Million USD | -575.862% |
| Aytu BioPharma, Inc. | -15.84 Million USD | -259.985% |
| SIGA Technologies, Inc. | 68.06 Million USD | 183.792% |
| Tilray Brands, Inc. | -244.98 Million USD | 76.718% |
| Lifecore Biomedical, Inc. | 12.01 Million USD | 574.786% |
| Shineco, Inc. | -22.44 Million USD | -154.069% |
| PetIQ, Inc. | 2.13 Million USD | 2776.49% |
| Regencell Bioscience Holdings Limited | -4.3 Million USD | -1225.852% |
| Incannex Healthcare Limited | -18.45 Million USD | -208.987% |
| Neurocrine Biosciences, Inc. | 249.7 Million USD | 122.842% |
| Alimera Sciences, Inc. | -20.13 Million USD | -183.31% |
| Silver Spike Investment Corp. | 7.34 Million USD | 877.046% |
| Assertio Holdings, Inc. | -331.94 Million USD | 82.817% |
| Shuttle Pharmaceuticals Holdings, Inc. | -6.59 Million USD | -765.136% |
| Petros Pharmaceuticals, Inc. | -8.16 Million USD | -598.698% |
| Clever Leaves Holdings Inc. | -17.89 Million USD | -218.655% |
| Cyclo Therapeutics, Inc. | -20.05 Million USD | -184.365% |
| Avadel Pharmaceuticals plc | -160.27 Million USD | 64.414% |
| Hempacco Co., Inc. | -13.12 Million USD | -334.524% |
| Talphera, Inc. | -18.39 Million USD | -210.029% |
| Alvotech | -551.73 Million USD | 89.662% |
| Eagle Pharmaceuticals, Inc. | 35.64 Million USD | 260.025% |
| Lantheus Holdings, Inc. | 326.66 Million USD | 117.46% |
| Currenc Group, Inc. | -15.3 Million USD | -272.625% |
| Kamada Ltd. | 8.28 Million USD | 788.508% |
| Indivior PLC | 2 Million USD | 2951.8% |
| Evoke Pharma, Inc. | -7.79 Million USD | -631.954% |
| Cyclo Therapeutics, Inc. | -20.05 Million USD | -184.365% |
| Evolus, Inc. | -61.68 Million USD | 7.537% |
| HUTCHMED (China) Limited | 100.78 Million USD | 156.595% |
| Amphastar Pharmaceuticals, Inc. | 137.54 Million USD | 141.467% |
| Akanda Corp. | -32.27 Million USD | -76.718% |